As of 2025-07-07, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 23.3x | 21.6x |
| Forward P/E multiples | 22.8x - 24.2x | 23.5x |
| Fair Price | (95.78) - (97.99) | (94.97) |
| Upside | -281795.6% - -288295.8% | -279416.1% |
| Date | EV/EBITDA |
| 2025-07-03 | -1.49 |
| 2025-07-02 | -1.49 |
| 2025-07-01 | -1.49 |
| 2025-06-30 | -1.49 |
| 2025-06-27 | -1.49 |
| 2025-06-26 | -1.49 |
| 2025-06-25 | -1.49 |
| 2025-06-24 | -1.49 |
| 2025-06-23 | -1.49 |
| 2025-06-20 | -1.49 |
| 2025-06-18 | -1.49 |
| 2025-06-17 | -1.49 |
| 2025-06-16 | -1.49 |
| 2025-06-13 | -1.49 |
| 2025-06-12 | -1.49 |
| 2025-06-11 | -1.49 |
| 2025-06-10 | -1.49 |
| 2025-06-09 | -1.49 |
| 2025-06-06 | -1.49 |
| 2025-06-05 | -1.49 |
| 2025-06-04 | -1.49 |
| 2025-06-03 | -1.49 |
| 2025-06-02 | -1.49 |
| 2025-05-30 | -1.49 |
| 2025-05-29 | -1.49 |
| 2025-05-28 | -1.49 |
| 2025-05-27 | -1.49 |
| 2025-05-23 | -1.49 |
| 2025-05-22 | -1.49 |
| 2025-05-21 | -1.49 |
| 2025-05-20 | -1.49 |
| 2025-05-19 | -1.49 |
| 2025-05-16 | -1.50 |
| 2025-05-15 | -1.50 |
| 2025-05-14 | -1.50 |
| 2025-05-13 | -1.51 |
| 2025-05-12 | -1.52 |
| 2025-05-09 | -1.53 |
| 2025-05-08 | -1.52 |
| 2025-05-07 | -1.61 |
| 2025-05-06 | -1.61 |
| 2025-05-05 | -1.63 |
| 2025-05-02 | -1.62 |
| 2025-05-01 | -1.62 |
| 2025-04-30 | -1.62 |
| 2025-04-29 | -1.62 |
| 2025-04-28 | -1.62 |
| 2025-04-25 | -1.63 |
| 2025-04-24 | -1.63 |
| 2025-04-23 | -1.63 |